Emerging clinical picture of lymphangioleiomyomatosis.
PDF (80K)
Journal: 2005/November - Thorax
ISSN: 0040-6376
Abstract:
OBJECTIVE
To provide a comprehensive update of the clinical picture of lymphangioleiomyomatosis (LAM) using two large patient registries.
METHODS
A cross sectional questionnaire survey which included questions on 14 LAM symptoms, pneumothorax, tuberous sclerosis complex (TSC), date of diagnosis, and pulmonary function tests (PFTs).
RESULTS
The response rate was 70.5% (n = 328). The mean age at the time of the survey was 46.7 years. The mean age at diagnosis was 42.7 years for women diagnosed 1 year before the survey and 35.8 years for women diagnosed 10 years previously. The main symptoms were dyspnoea (74%), fatigue (72%), cough (47%) and chest pain (44%); younger patients (<40 years) were less likely to report dyspnoea (p = 0.02). Patients with TSC (n = 51) were less likely to report dyspnoea (p = 0.05) and 76.5% reported angiomyolipoma (p < 0.0001) compared with patients with sporadic LAM. Patients with pneumothorax (63.0%) were less likely to report dyspnoea or fatigue (p < or = 0.05) than patients without pneumothorax. PFT results showed that low forced expiratory volume in 1 second and carbon monoxide transfer factor were highly associated with dyspnoea (p < 0.0001), but not with fatigue or history of pneumothorax.
CONCLUSIONS
Previously considered a condition of women of childbearing age, more older women (50% without pneumothorax) are now being diagnosed with LAM. LAM should be considered in women over 40 with unexplained dyspnoea. LAM patients with pneumothorax have less fatigue and less dyspnoea than those without pneumothorax. Fatigue has been overlooked as a symptom of LAM and appears across the spectrum of pulmonary function.
Open in
PUBMED | DOI | PMC | Google Scholar | Wikipedia
Relations:
Content
Citations
(15)
References
(24)
Diseases
(4)
Conditions
(2)
Organisms
(1)
Processes
(1)
Similar articles
Articles by the same authors
Discussion board
Thorax 60(10): 875-879
PMID: 16055626

Emerging clinical picture of lymphangioleiomyomatosis

Abstract

Objective: To provide a comprehensive update of the clinical picture of lymphangioleiomyomatosis (LAM) using two large patient registries.

Methods: A cross sectional questionnaire survey which included questions on 14 LAM symptoms, pneumothorax, tuberous sclerosis complex (TSC), date of diagnosis, and pulmonary function tests (PFTs).

Results: The response rate was 70.5% (n = 328). The mean age at the time of the survey was 46.7 years. The mean age at diagnosis was 42.7 years for women diagnosed 1 year before the survey and 35.8 years for women diagnosed 10 years previously. The main symptoms were dyspnoea (74%), fatigue (72%), cough (47%) and chest pain (44%); younger patients (<40 years) were less likely to report dyspnoea (p = 0.02). Patients with TSC (n = 51) were less likely to report dyspnoea (p = 0.05) and 76.5% reported angiomyolipoma (p<0.0001) compared with patients with sporadic LAM. Patients with pneumothorax (63.0%) were less likely to report dyspnoea or fatigue (p⩽0.05) than patients without pneumothorax. PFT results showed that low forced expiratory volume in 1 second and carbon monoxide transfer factor were highly associated with dyspnoea (p<0.0001), but not with fatigue or history of pneumothorax.

Conclusion: Previously considered a condition of women of childbearing age, more older women (50% without pneumothorax) are now being diagnosed with LAM. LAM should be considered in women over 40 with unexplained dyspnoea. LAM patients with pneumothorax have less fatigue and less dyspnoea than those without pneumothorax. Fatigue has been overlooked as a symptom of LAM and appears across the spectrum of pulmonary function.

Full Text

The Full Text of this article is available as a PDF (80K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Sullivan EJ. Lymphangioleiomyomatosis: a review. Chest. 1998 Dec;114(6):1689–1703. [PubMed] [Google Scholar]
  • Avila NA, Bechtle J, Dwyer AJ, Ferrans VJ, Moss J. Lymphangioleiomyomatosis: CT of diurnal variation of lymphangioleiomyomas. Radiology. 2001 Nov;221(2):415–421. [PubMed] [Google Scholar]
  • Taveira-DaSilva Angelo M, Stylianou Mario P, Hedin Carolyn J, Kristof Arnold S, Avila Nilo A, Rabel Antoinette, Travis William D, Moss Joel. Maximal oxygen uptake and severity of disease in lymphangioleiomyomatosis. Am J Respir Crit Care Med. 2003 Dec 15;168(12):1427–1431. [PubMed] [Google Scholar]
  • Boehler A, Speich R, Russi EW, Weder W. Lung transplantation for lymphangioleiomyomatosis. N Engl J Med. 1996 Oct 24;335(17):1275–1280. [PubMed] [Google Scholar]
  • Pechet Taine T, Meyers Bryan F, Guthrie Tracey J, Battafarano Richard J, Trulock Elbert P, Cooper Joel D, Patterson G Alexander. Lung transplantation for lymphangioleiomyomatosis. J Heart Lung Transplant. 2004 Mar;23(3):301–308. [PubMed] [Google Scholar]
  • Costello LC, Hartman TE, Ryu JH. High frequency of pulmonary lymphangioleiomyomatosis in women with tuberous sclerosis complex. Mayo Clin Proc. 2000 Jun;75(6):591–594. [PubMed] [Google Scholar]
  • Moss J, Avila NA, Barnes PM, Litzenberger RA, Bechtle J, Brooks PG, Hedin CJ, Hunsberger S, Kristof AS. Prevalence and clinical characteristics of lymphangioleiomyomatosis (LAM) in patients with tuberous sclerosis complex. Am J Respir Crit Care Med. 2001 Aug 15;164(4):669–671. [PubMed] [Google Scholar]
  • Hancock E, Tomkins S, Sampson J, Osborne J. Lymphangioleiomyomatosis and tuberous sclerosis. Respir Med. 2002 Jan;96(1):7–13. [PubMed] [Google Scholar]
  • Strizheva GD, Carsillo T, Kruger WD, Sullivan EJ, Ryu JH, Henske EP. The spectrum of mutations in TSC1 and TSC2 in women with tuberous sclerosis and lymphangiomyomatosis. Am J Respir Crit Care Med. 2001 Jan;163(1):253–258. [PubMed] [Google Scholar]
  • Johnson SR, Tattersfield AE. Clinical experience of lymphangioleiomyomatosis in the UK. Thorax. 2000 Dec;55(12):1052–1057.[PMC free article] [PubMed] [Google Scholar]
  • Urban T, Lazor R, Lacronique J, Murris M, Labrune S, Valeyre D, Cordier JF. Pulmonary lymphangioleiomyomatosis. A study of 69 patients. Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P). Medicine (Baltimore) 1999 Sep;78(5):321–337. [PubMed] [Google Scholar]
  • Seyama K, Kira S, Takahashi H, Ohnishi M, Kodama Y, Dambara T, Kobayashi J, Kitamura S, Fukuchi Y. Longitudinal follow-up study of 11 patients with pulmonary lymphangioleiomyomatosis: diverse clinical courses of LAM allow some patients to be treated without anti-hormone therapy. Respirology. 2001 Dec;6(4):331–340. [PubMed] [Google Scholar]
  • Lim Kun Eng, Tsai Ying Huang, Hsu Yl Yuan li, Hsu Wc Wen chen. Pulmonary lymphangioleiomyomatosis. High-resolution CT findings in 11 patients and compared with the literature. Clin Imaging. 2004 Jan-Feb;28(1):1–5. [PubMed] [Google Scholar]
  • Paciocco Giuseppe, Uslenghi Elisabetta, Bianchi Achille, Mazzarella Gennaro, Roviaro Giancarlo C, Vecchi Giuseppe, Harari Sergio. Diffuse cystic lung diseases: correlation between radiologic and functional status. Chest. 2004 Jan;125(1):135–142. [PubMed] [Google Scholar]
  • Taylor JR, Ryu J, Colby TV, Raffin TA. Lymphangioleiomyomatosis. Clinical course in 32 patients. N Engl J Med. 1990 Nov 1;323(18):1254–1260. [PubMed] [Google Scholar]
  • Hancock E, Osborne J. Lymphangioleiomyomatosis: a review of the literature. Respir Med. 2002 Jan;96(1):1–6. [PubMed] [Google Scholar]
  • Johnson S. Rare diseases. 1. Lymphangioleiomyomatosis: clinical features, management and basic mechanisms. Thorax. 1999 Mar;54(3):254–264.[PMC free article] [PubMed] [Google Scholar]
  • Chu SC, Horiba K, Usuki J, Avila NA, Chen CC, Travis WD, Ferrans VJ, Moss J. Comprehensive evaluation of 35 patients with lymphangioleiomyomatosis. Chest. 1999 Apr;115(4):1041–1052. [PubMed] [Google Scholar]
  • Karlsen K, Larsen JP, Tandberg E, Jørgensen K. Fatigue in patients with Parkinson's disease. Mov Disord. 1999 Mar;14(2):237–241. [PubMed] [Google Scholar]
  • Breslin E, van der Schans C, Breukink S, Meek P, Mercer K, Volz W, Louie S. Perception of fatigue and quality of life in patients with COPD. Chest. 1998 Oct;114(4):958–964. [PubMed] [Google Scholar]
  • Fisk JD, Pontefract A, Ritvo PG, Archibald CJ, Murray TJ. The impact of fatigue on patients with multiple sclerosis. Can J Neurol Sci. 1994 Feb;21(1):9–14. [PubMed] [Google Scholar]
  • Ream E, Richardson A. Fatigue in patients with cancer and chronic obstructive airways disease: a phenomenological enquiry. Int J Nurs Stud. 1997 Feb;34(1):44–53. [PubMed] [Google Scholar]
  • Taveira-DaSilva AM, Hedin C, Stylianou MP, Travis WD, Matsui K, Ferrans VJ, Moss J. Reversible airflow obstruction, proliferation of abnormal smooth muscle cells, and impairment of gas exchange as predictors of outcome in lymphangioleiomyomatosis. Am J Respir Crit Care Med. 2001 Sep 15;164(6):1072–1076. [PubMed] [Google Scholar]
  • Lazor Romain, Valeyre Dominique, Lacronique Jacques, Wallaert Benoît, Urban Thierry, Cordier Jean-François. Low initial KCO predicts rapid FEV1 decline in pulmonary lymphangioleiomyomatosis. Respir Med. 2004 Jun;98(6):536–541. [PubMed] [Google Scholar]
Centre for Research in Women's Health, Institute of Medical Sciences, Toronto, Ontario, Canada M5G 1N8. ac.ratsi@nehocmm
Centre for Research in Women's Health, Institute of Medical Sciences, Toronto, Ontario, Canada M5G 1N8. ac.ratsi@nehocmm
Copyright notice

Abstract

Objective: To provide a comprehensive update of the clinical picture of lymphangioleiomyomatosis (LAM) using two large patient registries.

Methods: A cross sectional questionnaire survey which included questions on 14 LAM symptoms, pneumothorax, tuberous sclerosis complex (TSC), date of diagnosis, and pulmonary function tests (PFTs).

Results: The response rate was 70.5% (n = 328). The mean age at the time of the survey was 46.7 years. The mean age at diagnosis was 42.7 years for women diagnosed 1 year before the survey and 35.8 years for women diagnosed 10 years previously. The main symptoms were dyspnoea (74%), fatigue (72%), cough (47%) and chest pain (44%); younger patients (<40 years) were less likely to report dyspnoea (p = 0.02). Patients with TSC (n = 51) were less likely to report dyspnoea (p = 0.05) and 76.5% reported angiomyolipoma (p<0.0001) compared with patients with sporadic LAM. Patients with pneumothorax (63.0%) were less likely to report dyspnoea or fatigue (p⩽0.05) than patients without pneumothorax. PFT results showed that low forced expiratory volume in 1 second and carbon monoxide transfer factor were highly associated with dyspnoea (p<0.0001), but not with fatigue or history of pneumothorax.

Conclusion: Previously considered a condition of women of childbearing age, more older women (50% without pneumothorax) are now being diagnosed with LAM. LAM should be considered in women over 40 with unexplained dyspnoea. LAM patients with pneumothorax have less fatigue and less dyspnoea than those without pneumothorax. Fatigue has been overlooked as a symptom of LAM and appears across the spectrum of pulmonary function.

Abstract
Full Text
Selected References
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.